Compounds > n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine
Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and pamaquine

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with pamaquine in 1 studies

Compound Research Comparison

Studies
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Trials
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Recent Studies (post-2010)
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Studies
(pamaquine)		Trials
(pamaquine)		Recent Studies (post-2010) (pamaquine)
791167904

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishiura, S; Nakase, H; Nonaka, I; Sugita, H; Tada, A1

Other Studies

1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and pamaquine

ArticleYear
Two-step mechanism of myofibrillar protein degradation in acute plasmocid-induced muscle necrosis.
    Biochimica et biophysica acta, 1984, Apr-24, Volume: 798, Issue:3

    Topics: Actinin; Aminoquinolines; Animals; Egtazic Acid; Leucine; Lysosomes; Male; Muscle Proteins; Muscles; Necrosis; Phagocytosis; Protease Inhibitors; Rats; Rats, Inbred Strains

1984